1. Home
  2. FSTR vs AVXL Comparison

FSTR vs AVXL Comparison

Compare FSTR & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L.B. Foster Company

FSTR

L.B. Foster Company

HOLD

Current Price

$39.46

Market Cap

308.9M

Sector

Industrials

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.36

Market Cap

289.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSTR
AVXL
Founded
1902
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.9M
289.1M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
FSTR
AVXL
Price
$39.46
$3.36
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$32.00
$22.00
AVG Volume (30 Days)
129.6K
871.6K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$540,009,000.00
N/A
Revenue This Year
$5.12
N/A
Revenue Next Year
$2.78
N/A
P/E Ratio
$52.59
N/A
Revenue Growth
1.74
N/A
52 Week Low
$17.69
$2.61
52 Week High
$36.49
$13.99

Technical Indicators

Market Signals
Indicator
FSTR
AVXL
Relative Strength Index (RSI) 86.16 47.40
Support Level $25.81 $2.93
Resistance Level N/A $3.76
Average True Range (ATR) 1.36 0.18
MACD 0.77 0.03
Stochastic Oscillator 96.43 23.81

Price Performance

Historical Comparison
FSTR
AVXL

About FSTR L.B. Foster Company

L.B. Foster Co is a technology solutions provider of products and services for the rail and infrastructure markets. The company has two reporting segments: Rail, Technologies, and Services (Rail); and Infrastructure Solutions (Infrastructure). Maximum revenue is generated from the Rail segment, which is comprised of several manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies throughout the world. The Infrastructure segment offers engineered precast concrete solutions, as well as fabricated bridge, protective pipe coating, and pipe threading offerings across North America. Geographically, the company generates maximum revenue from the United States, followed by Canada, the UK, and other markets.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: